AR045371A1 - ANTIGONISTS 4-CYCLALKYLAMINOPIRAZOL PYRIMIDINE OF NMDA / NR2B - Google Patents
ANTIGONISTS 4-CYCLALKYLAMINOPIRAZOL PYRIMIDINE OF NMDA / NR2BInfo
- Publication number
- AR045371A1 AR045371A1 ARP040102917A AR045371A1 AR 045371 A1 AR045371 A1 AR 045371A1 AR P040102917 A ARP040102917 A AR P040102917A AR 045371 A1 AR045371 A1 AR 045371A1
- Authority
- AR
- Argentina
- Prior art keywords
- nmda
- substituted
- nr2b
- cyclalkylaminopirazol
- antigonists
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos y sales farmacéuticamente aceptables de los mismos, que son eficaces como antagonistas de NMDA/NR2B, útiles para tratar afecciones neurológicas como por ejemplo el dolor, enfermedad de Parkinson, enfermedad de Alzheimer, epilepsia, depresión, ansiedad, daño isquémico cerebral, incluyendo la apoplejía y otras afecciones. Reivindicación 1: Un compuesto que tiene la fórmula (1) en la que R1 es un resto de fórmula (2), no sustituido o sustituido con un halógeno o -R2, donde R2 es alquilo C1-6, independientemente no sustituido o sustituido con uno o más halógenos; Y es alquilo C1-6, independientemente no sustituido o sustituido con uno o más halógenos; y sales farmacéuticamente aceptables del mismo y enantiómeros y diastereómeros individuales del mismo.Pharmaceutically acceptable compounds and salts thereof, which are effective as NMDA / NR2B antagonists, useful for treating neurological conditions such as pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, cerebral ischemic damage, including stroke and other conditions. Claim 1: A compound having the formula (1) wherein R1 is a moiety of formula (2), unsubstituted or substituted with a halogen or -R2, wherein R2 is C1-6 alkyl, independently unsubstituted or substituted with one or more halogens; Y is C1-6 alkyl, independently unsubstituted or substituted with one or more halogens; and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP040102917 AR045371A1 (en) | 2004-08-13 | 2004-08-13 | ANTIGONISTS 4-CYCLALKYLAMINOPIRAZOL PYRIMIDINE OF NMDA / NR2B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP040102917 AR045371A1 (en) | 2004-08-13 | 2004-08-13 | ANTIGONISTS 4-CYCLALKYLAMINOPIRAZOL PYRIMIDINE OF NMDA / NR2B |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045371A1 true AR045371A1 (en) | 2005-10-26 |
Family
ID=42778392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102917 AR045371A1 (en) | 2004-08-13 | 2004-08-13 | ANTIGONISTS 4-CYCLALKYLAMINOPIRAZOL PYRIMIDINE OF NMDA / NR2B |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR045371A1 (en) |
-
2004
- 2004-08-13 AR ARP040102917 patent/AR045371A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP056192A (en) | 3-FLUORO-PIPERIDINS AS ANTAGONISTS OF NMDA / NR2B | |
UY26872A1 (en) | DERIVATIVES OF THE 4- PIRIDINE PHENYL | |
AR069849A1 (en) | HETEROARILO DERIVATIVES AS AN OREXINE RECEIVER ANTAGONISTS | |
PE20081530A1 (en) | NEW COMPOUNDS 617 | |
AR058885A1 (en) | 3,5-SUBSTITUTED PIPERIDINE COMPOUNDS | |
AR065587A1 (en) | AMINOAMIDS AS AN OREXINE ANTAGONISTS | |
ECSP066858A (en) | GSK-3 INHIBITORS | |
AR062387A2 (en) | THE USE OF A COMPOUND DERIVED FROM IMIDAZO [1,2-A] PIRIDINA, AND A MEDICINAL PRODUCT CONTAINING IT | |
AR070234A1 (en) | COMPOUNDS THAT INCLUDE A CICLOBUTOXI GROUP | |
RU2008111991A (en) | ORGANIC COMPOUNDS | |
AR050435A1 (en) | HYDROXYAMIDE DERIVATIVES, OBTAINING PROCESSES AND PHARMACEUTICAL COMPOSITIONS. | |
CR9980A (en) | IMIDAZOLINS 4,4,5,5 TETRASUSTITUIDAS | |
AR058287A1 (en) | ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | |
PE20191784A1 (en) | VMAT2 INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS RELATING TO THEM | |
AR071925A1 (en) | MALONAMIDS AS AN OREXINE ANTAGONISTS | |
GT200500242A (en) | PROCESSES FOR THE PREPARATION OF 2- (2,6-DIOXOPIPERIDIN-3-IL) -1-SUBSTITUTED OXOISOINDOLINES | |
UY26086A1 (en) | PROCEDURES AND INTERMEDIATES TO PREPARE ANTI-CANCER COMPOUNDS | |
AR052156A1 (en) | FENIL-METANONAS BI- AND SUBSTITUTED TRICYCLES FOR THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | |
PE20061295A1 (en) | ACETYLENE DERIVATIVES | |
PE20152032A1 (en) | 3,4-DIHYDROISOQUINOLIN-2 (1H) -IL COMPOUNDS | |
CL2003002665A1 (en) | COMPOUNDS DERIVED FROM CARBOXILIC ACIDS, ITS SALTS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION, AND ITS USE IN THE TREATMENT OF DISEASES WHERE AN INHIBITOR OF THE FACTOR Xa AND / OR AN INHIBITOR OF SERINA PROTEASA IS NECESSARY. | |
CR11620A (en) | Derivatives of Imadazo- [1,2, b] -Piridazine for the Treatment of Tyrosine C-Met Tyrosine-mediated Disease | |
UY29197A1 (en) | N-SULPHONYLAMINOBENCIL-2-PHENOXYACETAMIDE SUBSTITUTED COMPOUNDS | |
AR050297A1 (en) | SUBSTITUTED HYDANTOINS | |
CO6260069A2 (en) | TIAZOLOPIRIDIN-2-ILOXI-FENIL AND TIAZOLOPIRAZIN-2-ILOXI-FENIL AMINAS AS MODULATORS OF LEUCOTRENE A4 HYDROLASS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |